These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 1624108)

  • 1. Selection of a Borrelia burgdorferi antigenic variant by cultivation in the presence of increasing amounts of homologous immune serum.
    Cinco M
    FEMS Microbiol Lett; 1992 Apr; 71(1):15-8. PubMed ID: 1624108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stability of Borrelia burgdorferi outer surface protein C under immune selection pressure.
    Hodzic E; Feng S; Barthold SW
    J Infect Dis; 2000 Feb; 181(2):750-3. PubMed ID: 10669369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Animal and human antibodies reactive with the outer surface protein A and B of Borrelia burgdorferi are borreliacidal, in vitro, in the presence of complement.
    Sambri V; Armati S; Cevenini R
    FEMS Immunol Med Microbiol; 1993 Jun; 7(1):67-71. PubMed ID: 8364524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors influencing the antigenic reactivity of Borrelia burgdorferi, the Lyme disease spirochete.
    Schwan TG; Simpson WJ
    Scand J Infect Dis Suppl; 1991; 77():94-101. PubMed ID: 1947819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antigenic and genetic structure of Borrelia burgdorferi.
    Gutiérrez Fernández J; Rodríguez Fernández M; Nuñez Murillo F; Maroto Vela MC
    Microbios; 1997; 91(368-369):165-74. PubMed ID: 9523423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of Borrelia burgdorferi associated antigens by monoclonal antibodies.
    Kramer MD; Schaible UE; Wallich R; Moter SE; Petzoldt D; Simon MM
    Immunobiology; 1990 Nov; 181(4-5):357-66. PubMed ID: 2099905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maintenance of infective Borrelia burgdorferi Sh-2-82 in 4% oxygen - 5% carbon dioxide in vitro.
    Austin FE
    Can J Microbiol; 1993 Dec; 39(12):1103-10. PubMed ID: 8131108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Use of western-immunoblotting to determine serum IgG-antibodies to antigens of different genotypes of Borrelia--Borrelia burgdorferi sensu stricto, Borrelia afzelii, and Borrelia garinii].
    Anan'eva LP; Nasonova VA; Barskova VG; Stir AS
    Med Parazitol (Mosk); 2002; (2):5-8. PubMed ID: 12214528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An immunodominant conserved region within the variable domain of VlsE, the variable surface antigen of Borrelia burgdorferi.
    Liang FT; Alvarez AL; Gu Y; Nowling JM; Ramamoorthy R; Philipp MT
    J Immunol; 1999 Nov; 163(10):5566-73. PubMed ID: 10553085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of isolation rate of Borrelia burgdorferi sensu lato in MKP and BSK-II medium.
    Ruzić-Sabljić E; Lotric-Furlan S; Maraspin V; Cimperman J; Logar M; Jurca T; Strle F
    Int J Med Microbiol; 2006 May; 296 Suppl 40():267-73. PubMed ID: 16530005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional heterogeneity in the antibodies produced to Borrelia burgdorferi.
    Benach JL
    Wien Klin Wochenschr; 1999 Dec; 111(22-23):985-9. PubMed ID: 10666815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of an immunoreactive 93-kDa core protein of Borrelia burgdorferi with a human IgG monoclonal antibody.
    Volkman DJ; Luft BJ; Gorevic PD; Schultz J; Padovano L
    J Immunol; 1991 May; 146(9):3177-82. PubMed ID: 2016542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retention of B. burgdorferi pathogenicity and infectivity after multiple passages in a co-culture system.
    Güner ES
    Experientia; 1994 Jan; 50(1):54-9. PubMed ID: 8293801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunological characterization of a low molecular mass polypeptidic antigen of Borrelia burgdorferi.
    Sambri V; Moroni A; Massaria F; Brocchi E; De Simone F; Cevenini R
    FEMS Microbiol Immunol; 1991 Nov; 3(6):345-9. PubMed ID: 1725956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of plasmids of Borrelia burgdorferi sensu lato during prolonged in vitro cultivation.
    Biškup UG; Strle F; Ružić-Sabljić E
    Plasmid; 2011 Oct; 66(1):1-6. PubMed ID: 21419795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody-resistant mutants of Borrelia burgdorferi: in vitro selection and characterization.
    Sădziene A; Rosa PA; Thompson PA; Hogan DM; Barbour AG
    J Exp Med; 1992 Sep; 176(3):799-809. PubMed ID: 1339462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complement-mediated killing of the Lyme disease spirochete Borrelia burgdorferi. Role of antibody in formation of an effective membrane attack complex.
    Kochi SK; Johnson RC; Dalmasso AP
    J Immunol; 1991 Jun; 146(11):3964-70. PubMed ID: 2033266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of an enzyme-linked immunosorbent assay that uses the 41-kd flagellin as the antigen for detection of antibodies to Borrelia burgdorferi in cattle.
    Ji B; Thomas CB; Collins MT
    Am J Vet Res; 1994 Sep; 55(9):1213-9. PubMed ID: 7802386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isolation of Borrelia burgdorferi from a Lyme seronegative patient in northern Italy: expression of OspB immunodominant proteins on the isolated strain.
    Cinco M; Trevisan G; Agolzer A
    Microbiologica; 1992 Apr; 15(2):95-8. PubMed ID: 1602993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Growth inhibition of Borrelia burgdorferi sensu lato by antibodies. A contribution to understanding the pathogenesis and improving diagnosis of Lyme borreliosis].
    Sadziene A; Barbour AG
    Wien Med Wochenschr; 1995; 145(7-8):162-5. PubMed ID: 7610664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.